Because of its high expression in tumors even in the early stages, the evaluation of ADAM17 as a potential blood-based screening marker for early detection of ovarian cancer seemed rational for us and will be examined more closely [24] to potentially improve detection of ovarian cancer in earlier stages. The gene discussed is ADAM17; the disease is ovarian cancer.